Cetera Investment Advisers
XERS icon

Cetera Investment Advisers’s Xeris Biopharma Holdings XERS Stock Holding History

Cetera Investment Advisers’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
18,201
-26,196
-59% -$167K ﹤0.01% 4587
2026
Q1 		$258K Buy
44,397
+5,750
+15% +$38.1K ﹤0.01% 4116
2025
Q4 		$303K Sell
38,647
-1,371
-3% -$10.8K ﹤0.01% 3898
2025
Q3 		$326K Sell
40,018
-6,314
-14% -$41.9K ﹤0.01% 3757
2025
Q2 		$216K Buy
46,332
+1,735
+4% +$7.95K ﹤0.01% 3668
2025
Q1 		$245K Buy
+44,597
New +$180K ﹤0.01% 3436
2024
Q3 		– Sell
-118,443
Closed -$266K – 3924
2024
Q2 		$266K Sell
118,443
-122
-0.1% -$246 ﹤0.01% 3136
2024
Q1 		$262K Buy
+118,565
New +$307K ﹤0.01% 3157

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cetera Investment Advisers's XERS Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Xeris Biopharma Holdings (XERS) stake by 59% in Q2 2026, selling an estimated $167K and leaving 18,201 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #4587.

Cetera Investment Advisers first reported a position in XERS in Q1 2024 and has held it in 8 quarters since. The position peaked at $326K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Cetera Investment Advisers held 18,201 shares of Xeris Biopharma Holdings worth $144K as of Q2 2026.
  • Cetera Investment Advisers sold 26,196 Xeris Biopharma Holdings shares in Q2 2026, an estimated $167K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4587 holding.
  • Cetera Investment Advisers first reported a position in Xeris Biopharma Holdings in Q1 2024 and has held it in 8 quarters since.
  • Cetera Investment Advisers's Xeris Biopharma Holdings position peaked at $326K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.